The following is the latest list of selected news summaries by Kyodo News.----------Shionogi may apply for oral COVID pill approval next week in JapanTOKYO - Japanese pharmaceutical firm Shionogi & Co. said Monday it is looking to apply for approval of its oral COVID-19 drug as early as next week after mid-phase clinical trials showed it was effective in reducing the coronavirus in the body.The results of "Phase 2a" clinical trials of the drug known as S-217622 are "extremely good," Shionogi President Isao Teshirogi said during a press conference.---------…READ FULL ARTICLE